- Parties: The plaintiffs were Boehringer Ingelheim International GMBH and Boehringer Ingelheim (Canada) Ltd. The defendant was Dr. Reddy's Laboratories Ltd. - Subject Matter: This was an action under the Patented Medicines (NOC) Regulations. - Date: The hearing was set on Nov. 27, 2023. - Venue: This was a federal case before the Federal Court. - Amount: No financial award was specified.

No uploaded documents